U.S. Markets close in 6 hrs 5 mins

Inovalon Holdings, Inc. (INOV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.64-0.02 (-0.13%)
As of 9:55AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close18.66
Open18.73
Bid18.60 x 1000
Ask18.73 x 800
Day's Range18.60 - 18.85
52 Week Range13.39 - 27.93
Volume17,851
Avg. Volume521,856
Market Cap2.896B
Beta (5Y Monthly)0.74
PE Ratio (TTM)490.39
EPS (TTM)0.04
Earnings DateFeb 17, 2021 - Feb 22, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est25.19
  • Vibra Healthcare and Ernest Health Select Inovalon’s EASE® All-Payer Solution
    GlobeNewswire

    Vibra Healthcare and Ernest Health Select Inovalon’s EASE® All-Payer Solution

    Cloud-Based, SaaS Platform Empowers Increased Accuracy of Patient Data, Greater Administrative Efficiencies Across Commercial Payers and MedicareBOWIE, Md., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced separate 5-year agreements with two prominent post-acute care providers, Vibra Healthcare and Ernest Health. Inovalon’s services will enable greater administrative efficiency and increased accuracy of payment processes undertaken by Vibra Healthcare’s 34 facilities and Ernest Health’s 30 facilities, which offer inpatient rehabilitation hospital services, long-term acute care hospital services and skilled nursing across a combined 19 states. Healthcare providers must maintain the highest standards in managing the many data submissions and processing pertaining to their delivery of clinical care, associated claims, payments and receivables from commercial payers and Medicare, using multiple platforms to manage the complex workflow. This is both time and labor intensive and can result in unnecessary staff work, patient data errors and lost revenue.EASE® All-Payer combines a high-efficiency, cloud-based workflow engine with the industry’s broadest connectivity and advanced data intelligence to empower providers to efficiently manage the entire data and revenue cycle process of clinical encounter data, claims, and receivables accuracy from all commercial payers and Medicare on one integrated platform. Not only can providers using EASE® All-Payer achieve a 99% or higher clean claims rate thanks to client-specific, configurable payer rules and real-time eligibility integration, the application helps users gain operational insights and identify denial trends with advanced analytics and reporting. Within existing workflows in the EASE® All-Payer application, providers can receive and correct claims from Medicare and commercial payers, as well as receive and submit clinical documentation requests electronically directly from Medicare.Under these agreements, Vibra Healthcare and Ernest Health will leverage EASE® All-Payer, a full-service, claims and denial management workflow software suite of functionalities that uniquely helps providers manage both commercial payers and Medicare, available as a Module within the Inovalon ONE® Platform. Leveraging data-driven routing and a sophisticated analytics engine powered by the Inovalon ONE® Platform, EASE® All-Payer is the only solution available within the marketplace today that provides direct access to the Centers for Medicare & Medicaid Services (CMS) to monitor, edit and analyze claims using a single platform. “Vibra Healthcare’s mission is to provide patient care with a commitment to clinical service excellence, a culture that inspires teamwork, and a passionate workforce driven by a dedication to patient wellness,” said Brad Hollinger, chief executive officer at Vibra Healthcare. “The implementation of EASE® All-Payer enables our staff to streamline and accelerate our administrative processes to enable a greater focus on clinical quality outcomes for our patients.”“We are pleased to provide a data-driven Platform to support innovative providers such as Vibra Healthcare and Ernest Health to engage with payers and to manage their administrative processes in the most effective and efficient manner,” said Bud Meadows, president and general manager of Inovalon’s provider business. “Their ongoing commitment to a better patient experience reinforces our mission of helping to simplify the complexities of healthcare and improving clinical outcomes and financial performance throughout the healthcare ecosystem.”About the Inovalon ONE® PlatformThe Inovalon ONE® Platform is an integrated cloud-based platform of nearly 100 individual proprietary technology toolsets and deep data assets able to be rapidly configured to empower the operationalization of large-scale, data-driven healthcare initiatives. Each proprietary technology toolset, referred to as a Module, is informed by the data of billions of medical events within Inovalon’s proprietary datasets. Combinations of Modules are configured to empower highly differentiated solutions for client needs quickly and in a highly scalable fashion. The flexibility of the Platform’s modular design enables clients to integrate the Platform capabilities with their own internal capabilities or other third-party solutions. The Platform brings to the marketplace a highly extensible, national-scale capability to interconnect with the healthcare ecosystem on a massive scale, aggregate and analyze data in petabyte volumes, arrive at sophisticated insights in real time, and drive meaningful impact wherever it is analytically identified best to intervene and intuitively visualize data and information to inform business strategy and execution.About InovalonInovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Through the Inovalon ONE® Platform, Inovalon brings to the marketplace a national-scale capability to interconnect with the healthcare ecosystem, aggregate and analyze data in real time, and empower the application of resulting insights to drive meaningful impact at the point of care. Leveraging its Platform, unparalleled proprietary datasets, and industry-leading subject matter expertise, Inovalon enables better care, efficiency, and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon’s unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action®.” Supporting thousands of clients, including 24 of the top 25 U.S. health plans, 22 of the top 25 global pharma companies, 19 of the top 25 U.S. healthcare provider systems, and many of the leading pharmacy organizations, device manufacturers, and other healthcare industry constituents, Inovalon’s technology platforms and analytics are informed by data pertaining to more than one million physicians, 565,000 clinical facilities, 324 million Americans, and 58 billion medical events. For more information, visit www.inovalon.com.Contact:Kim E. Collins Senior Vice President, Corporate Communications kcollins@inovalon.com 301-809-4000 x1473Hulus Alpay Vice President, Investor Relations halpay@inovalon.com 301-809-4000 x1237

  • Inovalon to Support National Vaccine Adherence Programs
    GlobeNewswire

    Inovalon to Support National Vaccine Adherence Programs

    Nation’s Largest Vaccine Manufacturer Spearheading Initiative BOWIE, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading provider of cloud-based platforms empowering data-driven healthcare, today announced the launch of an Inovalon ONE® Platform configuration supporting multiple national vaccine adherence initiatives.The program involves organizations from across the healthcare ecosystem, including global pharmaceutical organizations, patient engagement services companies, and health plans, with the Inovalon ONE® Platform serving as the program’s overall national technology platform. One of the world’s leading pharmaceutical companies and largest manufacturers of vaccines within the U.S., and a variety of leading health plans have engaged with the program with additional top global pharmaceutical companies and health plans expected to join.“Adherence to vaccination schedules is critical for providing maximum effectiveness against vaccine-preventable diseases in the community,” said Keith Dunleavy, M.D., Inovalon’s chief executive officer and chairman of the board. “We are pleased to bring to bear the scale of the Inovalon ONE® Platform and its vast primary source datasets to empower successful adherence to vaccine schedules, especially at a time when we have seen the COVID-19 pandemic disrupt routine vaccinations, let alone the need for COVID-19 related vaccination initiatives.”A wide array of vaccinations are of rising importance to public health as highlighted by the emergence of the COVID-19 pandemic. Education, timely and complete vaccination consistent with recommended schedules is of public health importance, as absent or incomplete vaccination may result in either suboptimal or lack of disease protection for that patient while also supporting herd immunity within the overall population. However, patients frequently fail to attain appropriate and timely vaccinations, including course completion for vaccines that require multiple doses and/or follow-on doses.A recent analysis found that Medicare alone spent $106 billion on vaccine-preventable diseases over a 3-year period (2016–2018). More broadly, studies show that vaccines help to prevent up to 3 million deaths each year. Vaccine series completion, where patients are recommended to receive multiple doses, is a persistent challenge. Once initiating a vaccine series, dramatic patient attrition often occurs for subsequent doses. Individual and community protection that vaccines provide is compromised when these doses are missed or delayed. The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) recommends vaccine outreach programs to improve vaccine series compliance.The Inovalon ONE® Platform Vaccine Adherence Program leverages established healthcare ecosystem connectivity, data integration, normalization, and analyses across engaged health plan patients to assess clinical applicability as well as adherence to the applicable ACIP immunization schedule and guidelines. On behalf of the partnered health plans, identified patients are then contacted through omni-channel engagement modalities with information to educate and facilitate applicable vaccinations. The Inovalon ONE® Platform thereafter monitors ongoing data flows for data confirming subsequent treatment confirmations. The offering is provided in coordination with pharmaceutical companies, vaccine manufacturers, retail clinics, provider networks, and other related elements of the healthcare ecosystem, in collaboration with participating health plans to support a global focus on strengthening vaccine education and adherence initiatives.About the Inovalon ONE® PlatformThe Inovalon ONE® Platform is an integrated cloud-based platform of nearly 100 individual proprietary technology toolsets and deep data assets able to be rapidly configured to empower the operationalization of large-scale, data-driven healthcare initiatives. Each proprietary technology toolset, referred to as a Module, is informed by the data of billions of medical events within Inovalon’s proprietary datasets. Combinations of Modules are configured to empower highly differentiated solutions for client needs quickly and in a highly scalable fashion. The flexibility of the Platform’s modular design enables clients to integrate the Platform capabilities with their own internal capabilities or other third-party solutions. The Platform brings to the marketplace a highly extensible, national-scale capability to interconnect with the healthcare ecosystem on a massive scale, aggregate and analyze data in petabyte volumes, arrive at sophisticated insights in real time, and drive meaningful impact wherever it is analytically identified best to intervene and intuitively visualize data and information to inform business strategy and execution.About InovalonInovalon is a leading provider of cloud-based platforms empowering data-driven healthcare. Through the Inovalon ONE® Platform, Inovalon brings to the marketplace a national-scale capability to interconnect with the healthcare ecosystem, aggregate and analyze data in real time, and empower the application of resulting insights to drive meaningful impact at the point of care. Leveraging its Platform, unparalleled proprietary datasets, and industry-leading subject matter expertise, Inovalon enables better care, efficiency, and financial performance across the healthcare ecosystem. From health plans and provider organizations, to pharmaceutical, medical device, and diagnostics companies, Inovalon’s unique achievement of value is delivered through the effective progression of “Turning Data into Insight, and Insight into Action®.” Supporting thousands of clients, including 24 of the top 25 U.S. health plans, 22 of the top 25 global pharma companies, 19 of the top 25 U.S. healthcare provider systems, and many of the leading pharmacy organizations, device manufacturers, and other healthcare industry constituents, Inovalon’s technology platforms and analytics are informed by data pertaining to more than one million physicians, 565,000 clinical facilities, 324 million Americans, and 58 billion medical events. For more information, visit www.inovalon.com.Contact:Kim E. Collins Senior Vice President, Corporate Communications kcollins@inovalon.com 301-809-4000 x1473 Hulus Alpay Vice President, Investor Relations halpay@inovalon.com 301-809-4000 x1237

  • Benzinga

    Insider Buys Inovalon Shares

    Inovalon Holdings Inc (NASDAQ:INOV) was trading 3.1% higher from the previous closing price. Teuber William J Jr filed a Form 4 with the SEC on Monday, November 2. The insider bought 10,000 shares at an average price of $19.48. After the transaction, the executive's stake in Inovalon Holdings Inc. moved to 144,247 shares.The Importance of Insider Transactions Insider transactions shouldn't be used primarily to make an investing decision, however an insider transaction can be an important factor in the investing decision.Insiders buying stock after a notable sell off can indicate an insider's long-term belief in the success of the company; insiders buying stock at new highs can be an indication the exec doesn't feel the stock is overvalued. Conversely, insiders who are selling stock at new lows can potentially indicate some kind of capitulation moment. Insiders selling at new highs can indicate that exec wants to "take some profit" and "lock in a gain."Transaction Codes To Focus On Investors prefer focusing on transactions which take place in the open market, indicated in the Form 4 with codes P for purchase and S for sale. If the transaction was an open-market transaction, that means that the insider made a concious decision for the company's stock moving forward.Transaction codes other than P or S are often viewed with less conviction as they are often not tied to a decision by the exec. As an example, transaction code C indicates the conversion of an option. Transaction code A indicates the insider may have been forced to sell shares in order to receive compensation the exec was promised upon being hired by a company. See more from Benzinga * Click here for options trades from Benzinga * 12 Healthcare Stocks Moving In Thursday's Intraday Session * Earnings Scheduled For October 28, 2020(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.